Targeted Inhibition of Protein Biosynthesis sensitizes Cancer Cells to IRE1a-mediated Apoptosis as a Consequence of the unfolded protein response

Gsottberger F, Meier C, Ammon AM, Parker S, Wendland K, George R, Petkovic S, Mellenthin L, Emmerich C, Lutzny-Geier G, Mackensen A, Metzler M, Chandramohan V, Müller F (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 161-161

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Franziska Gsottberger Department of Medicine 5 – Haematology and Oncology Christina Meier Lehrstuhl für Innere Medizin V Anna-Maria Ammon Department of Medicine 5 – Haematology and Oncology Kerstin Wendland Department of Medicine 5 – Haematology and Oncology Rebekka George Lehrstuhl für Innere Medizin V Gloria Lutzny-Geier Department of Medicine 5 – Haematology and Oncology Andreas Mackensen Lehrstuhl für Innere Medizin V Markus Metzler Professur für Kinder- und Jugendmedizin mit dem Schwerpunkt Pädiatrische Onkologie und Hämatologie Fabian Müller Department of Medicine 5 – Haematology and Oncology

Involved external institutions

Duke University

United States (USA) (US)

How to cite

APA:

Gsottberger, F., Meier, C., Ammon, A.-M., Parker, S., Wendland, K., George, R.,... Müller, F. (2022). Targeted Inhibition of Protein Biosynthesis sensitizes Cancer Cells to IRE1a-mediated Apoptosis as a Consequence of the unfolded protein response. In ONCOLOGY RESEARCH AND TREATMENT (pp. 161-161). BASEL: KARGER.

MLA:

Gsottberger, Franziska, et al. "Targeted Inhibition of Protein Biosynthesis sensitizes Cancer Cells to IRE1a-mediated Apoptosis as a Consequence of the unfolded protein response." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2022. 161-161.

BibTeX: Download